Charles Rhyee
Stock Analyst at TD Cowen
(0.96)
# 3,844
Out of 4,966 analysts
52
Total ratings
37.14%
Success rate
-10.73%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Downgrades: Sell | $283 → $366 | $475.51 | -23.03% | 5 | Jul 23, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Hold | $254 → $157 | $177.94 | -11.77% | 4 | Apr 14, 2025 | |
| CAH Cardinal Health | Upgrades: Buy | $130 → $144 | $148.78 | -3.21% | 2 | Jan 8, 2025 | |
| CRL Charles River Laboratories International | Maintains: Hold | $203 → $227 | $163.31 | +39.00% | 5 | Nov 11, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $23 → $25 | $9.85 | +153.81% | 3 | Nov 11, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $9 → $8 | $7.73 | +3.49% | 6 | Oct 31, 2024 | |
| VEEV Veeva Systems | Maintains: Hold | $180 → $192 | $269.20 | -28.68% | 3 | Aug 29, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $14 → $16 | $4.35 | +267.82% | 7 | May 16, 2024 | |
| TALK Talkspace | Maintains: Outperform | $4 → $5 | $2.66 | +87.97% | 2 | May 3, 2023 | |
| AMWL American Well | Downgrades: Market Perform | $100 → $50 | $6.90 | +624.64% | 3 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $251 | $190.81 | +31.54% | 1 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $56 | $7.53 | +643.69% | 2 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $360 → $280 | $9.60 | +2,816.67% | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $50 | $9.65 | +418.13% | 2 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $325 → $361 | $686.64 | -47.43% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $35 | $25.90 | +35.14% | 1 | Feb 13, 2018 |
Medpace Holdings
Jul 23, 2025
Downgrades: Sell
Price Target: $283 → $366
Current: $475.51
Upside: -23.03%
ICON Public Limited Company
Apr 14, 2025
Downgrades: Hold
Price Target: $254 → $157
Current: $177.94
Upside: -11.77%
Cardinal Health
Jan 8, 2025
Upgrades: Buy
Price Target: $130 → $144
Current: $148.78
Upside: -3.21%
Charles River Laboratories International
Nov 11, 2024
Maintains: Hold
Price Target: $203 → $227
Current: $163.31
Upside: +39.00%
Fortrea Holdings
Nov 11, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $9.85
Upside: +153.81%
Teladoc Health
Oct 31, 2024
Maintains: Hold
Price Target: $9 → $8
Current: $7.73
Upside: +3.49%
Veeva Systems
Aug 29, 2024
Maintains: Hold
Price Target: $180 → $192
Current: $269.20
Upside: -28.68%
GoodRx Holdings
May 16, 2024
Maintains: Buy
Price Target: $14 → $16
Current: $4.35
Upside: +267.82%
Talkspace
May 3, 2023
Maintains: Outperform
Price Target: $4 → $5
Current: $2.66
Upside: +87.97%
American Well
Mar 23, 2023
Downgrades: Market Perform
Price Target: $100 → $50
Current: $6.90
Upside: +624.64%
Dec 6, 2022
Initiates: Outperform
Price Target: $251
Current: $190.81
Upside: +31.54%
Oct 20, 2022
Maintains: Outperform
Price Target: $70 → $56
Current: $7.53
Upside: +643.69%
Aug 16, 2022
Maintains: Outperform
Price Target: $360 → $280
Current: $9.60
Upside: +2,816.67%
Jun 21, 2022
Maintains: Outperform
Price Target: $48 → $50
Current: $9.65
Upside: +418.13%
Apr 18, 2022
Maintains: Outperform
Price Target: $325 → $361
Current: $686.64
Upside: -47.43%
Feb 13, 2018
Initiates: Market Perform
Price Target: $35
Current: $25.90
Upside: +35.14%